Myriad Genetics MYGN Impairment Charges
Impairment Charges at other companies
Other financials
Where this comes from
Reported directly by Myriad Genetics in its filing.
Tagged under the XBRL concept us-gaap:AssetImpairmentCharges.
The official record: Myriad Genetics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Myriad Genetics's impairment charges.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Myriad Genetics's impairment charges?
- Myriad Genetics (MYGN) reported impairment charges of $5.4M in Q1 2026.
- What is the long-term trend for Myriad Genetics's impairment charges?
- Over 4 years (2021 to 2025), Myriad Genetics's impairment charges has grown at a 265.0% compound annual growth rate (CAGR), from $1.8M to $319.4M.
- What does impairment charges mean?
- Non-cash asset impairment charges added back in the operating cash flow reconciliation since they don't represent cash outflows.